2023 Annual Report - Hikma
WEBLearn more about our acting responsibly strategy and commitments to sustainable business. Learn more about our proven track record of value creation, strategy and investment case. Explore what makes Hikma an outstanding destination to further your career. Hikma Annual Report 2023.
WEBThe Group recorded significant revenue deductions for the year ended 31 December 2023 and determined provisions for customer rebates of $27 million, indirect rebates of $67 million and returns of $133 million.
Hikma Pharmaceuticals - Wikipedia
WEBUS$192 million (2023) [1] Number of employees. 8,800 (2024) [2] Website. www.hikma.com. Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products.
Results and presentations - Hikma
WEBInvestors. Learn more about our proven track record of value creation, strategy and investment case. Investors
WEBHikma has once again delivered a strong financial performance in 2021, growing revenue, expanding core operating margin and generating strong cash flow. Group core basic earnings per share in 2021 grew by 13%. Return on invested capital 1 was 17.1%, demonstrating our efficiency at allocating capital and generating value.
Hikma Pharmaceuticals Revenue - Stock Analysis
WEB6 days ago · Hikma Pharmaceuticals had revenue of $1.57B USD in the half year ending June 30, 2024, with 29.35% growth. This brings the company's revenue in the last twelve months to $3.02B, up 10.47% year-over-year.
Hikma Pharmaceuticals Plc Revenue 2016-2023 - Macrotrends
WEBHikma Pharmaceuticals Plc annual revenue for 2023 was $2.875B, a 14.22% increase from 2022. Hikma Pharmaceuticals Plc annual revenue for 2022 was $2.517B, a 1.41% decline from 2021. Hikma Pharmaceuticals Plc annual revenue for 2021 was $2.553B, a 9.06% increase from 2020.
WEBHikma’s purpose to put better health within reach, every day drives us to bring important, quality and affordable medicines to people who need them. In 2020, the COVID-19 pandemic truly galvanised this mission. I am proud of the role we have played, along with many others in the pharmaceutical industry, in coming together to help healthcare
HKMPF | Hikma Pharmaceuticals PLC Financial Statements - WSJ
WEBHikma Pharmaceuticals PLC balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View HKMPF financial statements in full.
Annual Financial Report – Company Announcement - FT.com
WEBDec 31, 2021 · Annual Financial Report. Hikma Pharmaceuticals PLC. (the 'Company') Publication of 2021 Annual Report and Notice of AGM. LEI: 549300BNS685UXH4JI75. The Company will today publish on its...
Skip to content